Sunday, April 22, 2018
News Roundup

Drug costs surge for many older Americans, despite Medicare coverage

To avoid liver damage, Roberta Solar, a 71-year-old cancer patient, has to take a medicine called ursodiol, perhaps for the rest of her life.

Next year her annual out-of-pocket costs for the drug will jump from $93 to $1,878 - a rise of almost 2,000 percent, according to information that she and her husband recently received from the insurer that covers their medicines under Medicare.

The drug is just one of dozens of medications whose skyrocketing prices are increasingly hitting older Americans on fixed incomes. And that has renewed calls that the law be changed to allow Medicare, the government system that covers older Americans, to use its size and power to negotiate better drug prices.

"The cost of this generic drug has escalated beyond logic," said Ken Solar, Roberta's husband. The couple's new out-of-pocket cost for ursodiol, he said, would consume more than a month of their combined Social Security checks.

When Congress added a prescription drug benefit to Medicare in 2003, the pharmaceutical industry did not just get millions of new customers. But Congress also placed language in the law explicitly banning Medicare from using its power to negotiate lower drug prices.

The argument for the ban on such bargaining was that each insurer offering a Medicare drug plan would compete and keep prices under control through their own negotiations with the pharmaceutical companies.

For years, Medicare drug costs have been lower than analysts' initial projections, which seemed to confirm the system was working. Now, however, as is the case for prescription drugs covered by other programs, the cost to retirees is skyrocketing.

The cost of medicine per Medicare beneficiary rose 8.4 percent annually between 2013 and 2015, according to an analysis by the Kaiser Family Foundation, a nonprofit group that focuses on national health issues. That was more than twice as fast as the average 3.6 percent annual rise between 2006 and 2013, the group said.

In a Nov. 3 speech to pharmaceutical executives gathered at the Ritz-Carlton hotel in Washington, D.C., Andy Slavitt, the acting administrator of the Centers for Medicare and Medicaid Services, called the recent price hikes on dozens of drugs "unsustainable."

"The more data that's revealed," Slavitt told the executives, "the more bad actors you find, and I'm telling you now: It's too many."

At a campaign rally on Jan. 25 in Farmington, N.H., Donald Trump told a crowd of hundreds of supporters that if elected he would seek to allow Medicare to negotiate on drug prices. He said such a change could save billions of dollars a year.

"We don't do it. Why? Because of the drug companies," Trump said then.

President-elect Trump's staff did not return emails asking whether he still supported the change. His four-page policy statement on reforming the health system does not mention it.

The drug industry vigorously opposes any change. Companies say the current system of depending on insurers to negotiate with manufacturers is working to save on costs.

"Large, powerful purchasers negotiate discounts and rebates directly with manufacturers, saving money for both beneficiaries and taxpayers," said Allyson Funk, a spokeswoman for the industry's trade group, known as PhRMA.

She said proposals to change the program could end up "driving up premiums, reducing choice and restricting coverage."

Funk pointed to a recent report paid for by PhRMA that found that actual medicine costs to patients and the government in the program officially called Medicare Part D were 35 percent below list prices in a dozen categories of widely used drugs. The report attributed the cost savings to discounts and rebates negotiated by insurers.

Earlier this month, however, Medicare officials released data showing that actual rebates and discounts were far less than those in PhRMA's report. Officials said the Medicare drug insurers received $16 billion in rebates in 2014, or an average rebate of 17.5 percent off the list price, and that the program's rebates were generally lower than what private employers' and other insurance programs received.

"Part of the reason for this is that Medicare cannot harness its full purchasing power to negotiate for rebates across all Part D plans," they wrote in the Nov. 14 report.

Medicare's analysis also showed how the cost to taxpayers for the drug program is surging as prices continue to escalate. Taxpayers pick up 80 percent of a beneficiary's medicine costs once they exceed a certain threshold. Total costs for the Medicare drug benefit above that threshold surged by 85 percent from 2013 to 2015 to $51.3 billion, according to the report.

In 2017, taxpayers will cover 80 percent of drug costs after beneficiaries have paid $4,950 out-of-pocket.

The drug that Roberta Solar needs shows how industry competition has failed to hold down some prices.

Ursodiol is a generic that has been sold for decades. It was available for a list price as low as 45 cents a capsule until May 2014 when one of the firms — Lannett Co. — raised its price per pill to $5.10. Lannett's competitors quickly followed with their own price increases, with most offering the drug for about $5 a capsule.

"What did they do, put cocaine inside it?" asked Ken Solar, who lives with his wife in Garfield, N.J.

A spokesman for Lannett last week declined to comment.

Comments
District softball schedules for Tampa Bay

District softball schedules for Tampa Bay

Class 9A-8 (higher seed hosts)Tuesday: No. 3 Alonso at No. 2 Palm Harbor University, 4; No. 4 Sarasota Riverview at No. 1 Newsome, 7Thursday: Final, 4 or 7 (depending on who hosts)Class 8A-4 at Strawberry Crest Tuesday: No. 1 Wharton vs. No. 4 Wiregr...
Updated: 24 minutes ago
Teen killed in crash remembered as

Teen killed in crash remembered as "always smiling and laughing"

WEEKI WACHEE — Seth Leathers was on his way to play basketball at his church when he was killed Wednesday in a car crash on U.S. 19 in Spring Hill, according to family friend Laurie Pike.Leathers, 16, was the passenger in a car driven by his friend G...
Updated: 2 hours ago
Rays thoughts are with ex-teammate Danny Farquhar

Rays thoughts are with ex-teammate Danny Farquhar

Members of the Rays organization sent their thoughts and prayers to former teammate Danny Farquhar, who was hospitalized Saturday night in Chicago in stable but critical condition after suffering a brain hemorrhage caused by a ruptured aneurysm.Farqu...
Updated: 2 hours ago
Baseball: Bulls edge Knights to even series

Baseball: Bulls edge Knights to even series

After a two-hour weather delay Saturday evening at USF, the remote local threat of lightning finally dissipated.The postseason intensity never did.For the second consecutive night, the UCF-USF baseball series delivered, this time with the Bulls (25-1...
Updated: 9 hours ago
Perspective: The Heartland to Headwaters Florida Wildlife Corridor Expedition finds frustration and fear seeking a safe a path for wildlife across Interstate 4

Perspective: The Heartland to Headwaters Florida Wildlife Corridor Expedition finds frustration and fear seeking a safe a path for wildlife across Interstate 4

The original Florida Wildlife Corridor Expedition in 2012 was inspired by the how the Florida black bear roamed — and the space it needed to do so successfully. In 2010, expedition team member Joe Guthrie conducted research through the University of ...
Published: 04/22/18
Athletics’ Sean Manaea no-hits Red Sox

Athletics’ Sean Manaea no-hits Red Sox

OAKLAND, Calif. – Sean Manaea watched as Marcus Semien fired a ball from short to second baseman Jed Lowrie, turned around, and jumped into the arms of catcher Jonathan Lucroy. History was made at the Coliseum.Manaea no-hit the Red Sox on ...
Updated: 9 hours ago
Maple Leafs force Game 6 with Bruins

Maple Leafs force Game 6 with Bruins

BOSTON — Tyler Bozak and James van Riemsdyk scored 1:19 apart in the second period, and then the Maple Leafs killed off a 5-on-3 and three more power plays in a row to beat the Bruins 4-3 in Game 5 on Saturday night and avoid playoff eliminatio...
Updated: 10 hours ago
Marc Topkin’s takeaways from Rays’ 10-1 Saturday win over Twins

Marc Topkin’s takeaways from Rays’ 10-1 Saturday win over Twins

* Is it time to take the leap and believe this is the real Blake Snell? He talked a good game this spring and pitched well in his debut, but that rough second outing raised old doubts. But a good outing in Chicago and two dominant ones on the homesta...
Updated: 10 hours ago
Rays Tales: How low can this team go compared to those Devil Rays days?

Rays Tales: How low can this team go compared to those Devil Rays days?

When the Rays, in the opening weekend of their 20th anniversary celebration season, brought back and honored the inaugural 1998 Devil Rays squad, it got us thinking unexpected thoughts, such as which was a better team:The first one, or the current on...
Updated: 11 hours ago
Rays Journal: Team effort pays off in 10-1 win over Twins

Rays Journal: Team effort pays off in 10-1 win over Twins

ST. PETERSBURG – Let's be clear here, the Rays still have a long way to go, and a lot of ground to make up.But seeing them play like they did Saturday in beating the Twins 10-1, putting on a solid all-around show in cobbling their first three-g...
Updated: 11 hours ago